Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Launay

Showing results (241-250 of 305) with videos related to

Pageof 31
Sort By:
Infection|February 15, 2020
Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter studyFrançois Bénézit, Paul Loubet, Florence Galtier, et al.
The Journal of Infectious Diseases|July 16, 2025
Characteristics of Human Metapneumovirus Infection Compared to Respiratory Syncytial Virus and Influenza Infections in Adults Hospitalized for Influenza-Like Illness in France, 2012-2022Paul Loubet, Salomé Guitton, Simon Rolland, et al.
NPJ Vaccines|June 25, 2019
HIV therapeutic vaccine enhances non-exhausted CD4<sup>+</sup> T cells in a randomised phase 2 trialVincent Vieillard, Béhazine Combadière, Roland Tubiana, et al.
BMC Infectious Diseases|February 3, 2016
Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemyJulie Bucher, Pierre-Yves Boelle, Dominique Hubert, et al.
Scientific Reports|May 29, 2026
CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteersYves Levy, Christiane Moog, Aurélie Wiedemann, et al.
The Lancet. Infectious Diseases|November 20, 2020
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trialAndrew J Pollard, Odile Launay, Jean-Daniel Lelievre, et al.
Vaccine|September 6, 2022
Epidemiology and pre-vaccine burden of rotavirus diarrhea in Democratic Republic of Congo (DRC): Results of sentinel surveillance, 2009-2019Christophe Luhata Lungayo, Rachel M Burke, Aimé Cikomola, et al.
Scientific Reports|March 11, 2022
Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter studyDavid Luque-Paz, Pierre Tattevin, Paul Loubet, et al.
Ophthalmology|August 7, 2017
Prognostic Factors in Syphilitic UveitisFlorence Hoogewoud, Laure Frumholtz, Paul Loubet, et al.
AIDS (London, England)|November 27, 2014
Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adultsCatia Marzolini, Caroline Sabin, François Raffi, et al.
Pageof 31

Showing results (241-250 of 305) with videos related to

Sort By:
Pageof 31
Infection|February 15, 2020
Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter studyFrançois Bénézit, Paul Loubet, Florence Galtier, et al.
The Journal of Infectious Diseases|July 16, 2025
Characteristics of Human Metapneumovirus Infection Compared to Respiratory Syncytial Virus and Influenza Infections in Adults Hospitalized for Influenza-Like Illness in France, 2012-2022Paul Loubet, Salomé Guitton, Simon Rolland, et al.
NPJ Vaccines|June 25, 2019
HIV therapeutic vaccine enhances non-exhausted CD4<sup>+</sup> T cells in a randomised phase 2 trialVincent Vieillard, Béhazine Combadière, Roland Tubiana, et al.
BMC Infectious Diseases|February 3, 2016
Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemyJulie Bucher, Pierre-Yves Boelle, Dominique Hubert, et al.
Scientific Reports|May 29, 2026
CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteersYves Levy, Christiane Moog, Aurélie Wiedemann, et al.
The Lancet. Infectious Diseases|November 20, 2020
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trialAndrew J Pollard, Odile Launay, Jean-Daniel Lelievre, et al.
Vaccine|September 6, 2022
Epidemiology and pre-vaccine burden of rotavirus diarrhea in Democratic Republic of Congo (DRC): Results of sentinel surveillance, 2009-2019Christophe Luhata Lungayo, Rachel M Burke, Aimé Cikomola, et al.
Scientific Reports|March 11, 2022
Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter studyDavid Luque-Paz, Pierre Tattevin, Paul Loubet, et al.
Ophthalmology|August 7, 2017
Prognostic Factors in Syphilitic UveitisFlorence Hoogewoud, Laure Frumholtz, Paul Loubet, et al.
AIDS (London, England)|November 27, 2014
Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adultsCatia Marzolini, Caroline Sabin, François Raffi, et al.
Pageof 31